
非小细胞肺癌表皮生长因子受体-酪氨酸激酶抑制药治疗的现状与挑战
Current Situation and Challenges of EGFR-TKI in Non-Small Cell Lung Cancer
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |